Mariëtte J. Weterman

Author

Amsterdam UMC Location University of Amsterdam

Also Known As

M. J. Weterman, M. Weterman, M.J. Weterman, Mariette J. Weterman, Mariette Weterman, Mariëtte J Weterman, Mariëtte J. Weterman, Mariëtte Weterman, Pim Weijenborg

Publications

599

Citations

H-Index

Concepts

All Affiliations

Amsterdam UMC Location University of Amsterdam University of Amsterdam The Netherlands Cancer Institute Utrecht University

About

Mariëtte J. Weterman is an author at Amsterdam UMC Location University of Amsterdam specializing in cancer therapeutics, cancer research, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	372
2	Pathology	1	1	372
3	Cancer Therapeutics	1	1	372
4	Cancer Research	1	1	372
5	Oncology	1	1	372

Mariëtte J. Weterman

Publications

591

Citations

H-Index

Page 1

	Year	Citations
Metformin in patients with advanced pancreatic cancer: a double-blind, randomised, placebo-controlled phase 2 trial Sil Kordes, Michaël Pollak, Aeilko H. Zwinderman, The Lancet Oncology Placebo-controlled Phase 2OncologyPancreatic CancerGastrointestinal OncologyCancer Management	2015	372
Phase II study of capecitabine and the oral mTOR inhibitor everolimus in patients with advanced pancreatic cancer Sil Kordes, Heinz‐Josef Klümpen, Mariëtte J. Weterman, Cancer Chemotherapy and Pharmacology	2015	67
Adjuvant hepatic arterial infusion pump chemotherapy and resection versus resection alone in patients with low-risk resectable colorectal liver metastases – the multicenter randomized controlled PUMP trial Florian E. Buisman, Marjolein Y.V. Homs, Dirk J. Grünhagen, BMC Cancer	2019	57
A phase I/II, non-randomized, feasibility/safety and efficacy study of the combination of everolimus, cetuximab and capecitabine in patients with advanced pancreatic cancer Sil Kordes, Dick J. Richel, Heinz‐Josef Klümpen, Investigational New Drugs	2012	35
Phase I and pharmacokinetic study of capecitabine and the oral mTOR inhibitor everolimus in patients with advanced solid malignancies Maarten J. Deenen, Heinz‐Josef Klümpen, Dick J. Richel, Investigational New Drugs	2011	23
Images of God and attitudes towards death in relation to spiritual wellbeing: an exploratory side study of the EORTC QLQ-SWB32 validation study in palliative cancer patients Renske Kruizinga, Michael Scherer‐Rath, Mariëtte J. Weterman, BMC Palliative Care	2017	20
A phase Ib study of everolimus combined with metformin for patients with advanced cancer Remco J. Molenaar, Tim van de Venne, Mariëtte J. Weterman, Investigational New Drugs	2017	17

Page 1